A. D. David Mackay - Dec 30, 2022 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 04:08 PM
Previous filing
Sep 15, 2022
Next filing
Mar 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +42.5 +0.81% $0.00 5.32K Feb 11, 2022 Common Stock 42.5 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +39 +0.73% $0.00 5.36K May 13, 2022 Common Stock 39 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +43.2 +0.81% $0.00 5.4K Aug 12, 2022 Common Stock 43.2 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +44.2 +0.82% $0.00 5.44K Nov 10, 2022 Common Stock 44.2 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +1.07K +19.72% $0.00 6.52K Dec 30, 2022 Common Stock 1.07K Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.